JPMorgan Chase & Co’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-32
| Closed | -$33 | – | 6610 |
|
|
2025
Q1 | $33 | Sell |
32
-234
| -88% | -$241 | ﹤0.01% | 6173 |
|
|
2024
Q4 | $260 | Sell |
266
-6
| -2% | -$6 | ﹤0.01% | 5823 |
|
|
2024
Q3 | $400 | Sell |
272
-511
| -65% | -$751 | ﹤0.01% | 5751 |
|
|
2024
Q2 | $1.06K | Buy |
783
+512
| +189% | +$691 | ﹤0.01% | 5588 |
|
|
2024
Q1 | $444 | Buy |
271
+14
| +5% | +$23 | ﹤0.01% | 5721 |
|
|
2023
Q4 | $496 | Buy |
257
+6
| +2% | +$12 | ﹤0.01% | 5886 |
|
|
2023
Q3 | $602 | Sell |
251
-552
| -69% | -$1.32K | ﹤0.01% | 5739 |
|
|
2023
Q2 | $2.05K | Buy |
+803
| New | +$2.05K | ﹤0.01% | 5426 |
|
|
2022
Q4 | – | Sell |
-7
| Closed | – | – | 5939 |
|
|
2022
Q3 | $0 | Buy |
+7
| New | – | ﹤0.01% | 5829 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 5919 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 5954 |
|
|
2021
Q4 | – | Sell |
-8,582
| Closed | -$258K | – | 5919 |
|
|
2021
Q3 | $258K | Sell |
8,582
-7,750
| -47% | -$233K | ﹤0.01% | 4292 |
|
|
2021
Q2 | $758K | Buy |
16,332
+4,026
| +33% | +$187K | ﹤0.01% | 3788 |
|
|
2021
Q1 | $739K | Buy |
12,306
+1,933
| +19% | +$116K | ﹤0.01% | 3826 |
|
|
2020
Q4 | $543K | Buy |
10,373
+9,074
| +699% | +$475K | ﹤0.01% | 3698 |
|
|
2020
Q3 | $45K | Sell |
1,299
-7,171
| -85% | -$248K | ﹤0.01% | 4312 |
|
|
2020
Q2 | $735K | Buy |
8,470
+7,557
| +828% | +$656K | ﹤0.01% | 3152 |
|
|
2020
Q1 | $53K | Sell |
913
-181
| -17% | -$10.5K | ﹤0.01% | 4121 |
|
|
2019
Q4 | $79K | Buy |
1,094
+56
| +5% | +$4.04K | ﹤0.01% | 4098 |
|
|
2019
Q3 | $63K | Buy |
1,038
+212
| +26% | +$12.9K | ﹤0.01% | 4158 |
|
|
2019
Q2 | $69K | Buy |
826
+126
| +18% | +$10.5K | ﹤0.01% | 4139 |
|
|
2019
Q1 | $57K | Sell |
700
-28
| -4% | -$2.28K | ﹤0.01% | 4185 |
|
|
2018
Q4 | $118K | Buy |
728
+519
| +248% | +$84.1K | ﹤0.01% | 3982 |
|
|
2018
Q3 | $34K | Buy |
209
+106
| +103% | +$17.2K | ﹤0.01% | 4477 |
|
|
2018
Q2 | $15K | Buy |
+103
| New | +$15K | ﹤0.01% | 4565 |
|